Walker Ex Rel. Walker v. Merck & Co.

648 F. Supp. 931, 1986 U.S. Dist. LEXIS 17235
CourtDistrict Court, M.D. Georgia
DecidedNovember 26, 1986
DocketCiv. A. 85-202-1-MAC
StatusPublished
Cited by13 cases

This text of 648 F. Supp. 931 (Walker Ex Rel. Walker v. Merck & Co.) is published on Counsel Stack Legal Research, covering District Court, M.D. Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Walker Ex Rel. Walker v. Merck & Co., 648 F. Supp. 931, 1986 U.S. Dist. LEXIS 17235 (M.D. Ga. 1986).

Opinion

FITZPATRICK, District Judge:

Presently before this court is defendant’s motion for summary judgment. The material facts in this case are straightforward and undisputed. The case is a products liability suit brought by plaintiff, Tina Grimsley Walker, and her daughter, Luchelle Walker, against a pharmaceutical manufacturer, Merck & Co., Inc. (hereinafter Merck). Plaintiff Tina Grimsley Walker alleges injury to her daughter arising out of the mother’s receipt of a measles, mumps and rubella vaccine commonly known as “M-M-RII”. Merck manufactured the vaccine that plaintiffs allege caused the injury to Luchelle Walker.

I.

FACTS

In 1982, Bibb County maintained a program that required certain students attending public high schools in the county to be injected with the M-M-RII vaccine before being admitted to school. On January 5, 1982, Tina Grimsley Walker, then pregnant with Luchelle Walker, received the M-M-RII vaccine at the Bibb County Health Department. The vaccine was administered by a licensed practical nurse named Josephine Long. Mrs. Long has approximately twenty years experience as a licensed practical nurse. The M-M-RII that she administered was packaged in containers. Each container of the immunization serum included a circular describing the risks inherent in the M-M-RII vaccine. The circular states that one of the inherent risks of the vaccine is that it can cause injury to an unborn fetus. Because the effects of the vaccine on an unborn fetus are unknown, pregnant females are warned not to take the vaccine. The circulars contained in the containers adequately described the potential risks to an unborn fetus, including the fact that the vaccine can cause a child to be born blind.

*933 The nurse who administered the vaccine to Tina Grimsley Walker stated unequivocally that before she gave Walker the vaccine she inquired of Walker when her last period had occurred, she asked Walker if she were sexually active, and she asked Walker if there was any possibility whatsoever that she was pregnant. The nurse stated that Walker responded that she had had a period beginning December 13, 1981. According to the nurse, Walker also stated that she was not sexually active, and that there was no possibility of pregnancy. Walker, on the other hand, stated that she remembered the nurse having asked her when her last period was, but she did not remember specifically whether or not the nurse asked her about her sexual activity or about the possibility of pregnancy. However, this factual dispute is not material, and this case may be dismissed on defendant’s summary judgment motion without a determination of the veracity of either of these witnesses.

Additionally, Merck contracted with the Center for Disease Control (“CDC”), the distributor of the M-M-RII, to provide that each recipient of the drug would be warned of inherent risks. The CDC provided a consent form to be signed by each vaccinee, or his or her legal guardian, before the vaccine could be administered. The form clearly delineated all potential risks connected to the vaccine. The consent form included a paragraph on potential effects on an unborn fetus. Plaintiff’s mother, Vicki Unger, signed this consent form when she went to the Bibb County Health Department with her daughter the day the vaccine was administered.

On September 14, 1982, Luchelle Walker was bom to Tina Grimsley Walker. Luchelle’s visual capability is extremely limited, and plaintiffs allege that her blindness was proximately caused by the M-M-RII vaccine. More specifically, plaintiffs allege that Merck’s failure to warn them of M-M-RII’s risks proximately caused Luchelle’s injuries. Merck contends that the M-M-RII vaccine did not cause Luchelle Walker’s injuries, and, even assuming that it did, plaintiff was adequately warned of the potential danger associated with M-M-RII and nevertheless consented to the immunization.

II.

CONCLUSIONS OF LAW

In this products liability suit, involving what may be categorized as an “inherently dangerous” or “unavoidably unsafe” drug, the manufacturer’s duty is to properly prepare and properly market the drug, and to adequately warn about all inherent risks. Center Chemical Company v. Parzini, 234 Ga. 868, 218 S.E.2d 580 (1975). A manufacturer is not an insurer against all risks of injury associated with its product, and plaintiffs are not entitled to recover unless they can prove that the M-M-RII was defective. See Hunt v. Harley Davidson Motor Co., 147 Ga.App. 44, 248 S.E.2d 15 (1978). In determining the existence of a “defect” in the case of an inherently dangerous product, the Georgia Supreme Court has recognized that:

Strict liability is not imposed under the statute [O.C.G.A. § 51-1-11 (1982)] merely because a product may be dangerous. Many products cannot be made completely safe for use and some cannot be made safe at all. However, such products may be useful and desirable. If they are properly prepared, manufactured, packaged and accompanied with adequate warnings and instructions, they cannot be said to be defective. To hold otherwise would discourage the marketing of many products because some danger attended their use. We find nothing in [O.C.G.A. § 51-1-11] that makes a manufacturer strictly liable for such products absent a defect.

Parzini, 234 Ga. at 870, 218 S.E.2d at 582.

Luchelle Walker’s injuries are exactly those which Merck disclosed to the CDC as being a potential result of the drug’s effect on an unborn child. There is no contention here that Merck inadequately prepared or marketed the drug. Therefore, Merck can only be liable if this court *934 finds that Merck failed to adequately warn potential users of the drug of the inherent risks. Reyes v. Wyeth Laboratories, 498 F.2d 1264 (5th Cir.1974), cert. denied 419 U.S. 1096, 95 S.Ct. 687, 42 L.Ed.2d 688 (1974). Manufacturers in the situation of Merck, under Georgia law, must use reasonable care in warning users of such risks. Wells by Maihafer v. Ortho Pharmaceutical Corp., 615 F.Supp. 262 (N.D.Ga.1985), modified on other grounds 788 F.2d 741 (11th Cir.1986). This court finds that Merck took all precautions necessary as the manufacturer of M-M-RII to warn of any potential injury, and thus Merck is entitled to judgment as a matter of law. Fed.R.Civ.P. 56(c).

A. Merck’s duty was to warn the learned health professionals who administered M-M-RII of the risks inherent in the drug.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Stevens v. Novartis Pharmaceuticals Corp.
2010 MT 282 (Montana Supreme Court, 2010)
Larkin v. Pfizer, Inc.
153 S.W.3d 758 (Kentucky Supreme Court, 2004)
Allison v. Merck and Co., Inc.
878 P.2d 948 (Nevada Supreme Court, 1994)
Freeman v. United Cities Propane Gas of Georgia, Inc.
807 F. Supp. 1533 (M.D. Georgia, 1992)
Mazur v. Merck & Co.
964 F.2d 1348 (Third Circuit, 1992)
Mazur v. Merck & Co., Inc.
767 F. Supp. 697 (E.D. Pennsylvania, 1991)
Kociemba v. G.D. Searle & Co.
680 F. Supp. 1293 (D. Minnesota, 1988)
Walker v. Merck & Company, Inc.
831 F.2d 1069 (Eleventh Circuit, 1987)

Cite This Page — Counsel Stack

Bluebook (online)
648 F. Supp. 931, 1986 U.S. Dist. LEXIS 17235, Counsel Stack Legal Research, https://law.counselstack.com/opinion/walker-ex-rel-walker-v-merck-co-gamd-1986.